Location: Home
  • search
  • go
  • Relate News
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...
  • 2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer
  • 2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought
  • 2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises
  • 2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...
  • 2/13/2026Pentagon Reverses Decision After Briefly Listing WuXi AppTec as Chines...
  • 2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application
  • 2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/12/2026China Indicts AstraZeneca and Former China Head Leon Wang Over Data an...
  • 2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy
  • 2/12/2026RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials
  • 2/11/2026NHSA Issues Trial Measures for Early Communication on Reference Drugs
  • 2/11/2026China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
  • 2/11/2026Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...
  • 2/11/2026Madrigal Expands MASH Pipeline with Six siRNA Programs from China's Ri...
  • 2/11/2026Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...
  • 2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
  • 2/10/20263D Medicines Advances Envafolimab Toward Full Market Approval in China
  • 2/10/2026Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
  • Page:2/381 Total number of articles:11416: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group